Table 6. Maternal and perinatal outcomes of euthyroid women and those with SCH in the second trimester.
Outcome | Euthyroid (n = 2586) | SCH (n = 54) | P |
GH | 27 (1.044%) | 1 (1.851%) | 0.441 |
GDM | 127 (4.945%) | 2 (3.704%) | 1 |
Placenta previa | 3 (0.116%) | 0 (0%) | 1 |
Placental abruption | 2 (0.773%) | 0 (0%) | 1 |
PROM | 109 (4.215%) | 2 (3.703%) | 1 |
Premature delivery | 66 (2.126%) | 1 (1.852%) | 0.746 |
IUGR | 28 (1.083%) | 0 (0%) | 1 |
Fetal distress | 85 (3.287%) | 0 (0%) | 0.335 |
LBW | 46 (1.779%) | 0 (0%) | 1 |
Stillbirth | 4 (0.155%) | 2 (3.704%) | 0.006 |
Malformation | 11 (0.425%) | 2 (3.704%) | 0.028 |
SCH, subclinical hypothyroidism; GH, gestational hypertension; GDM, gestational diabetes mellitus; PROM, prelabor rupture of membranes; IUGR, intrauterine growth restriction; LBW, low birth weight.